| 000 | 01085 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250515124125.0 | ||
| 264 | 0 | _c20080908 | |
| 008 | 200809s 0 0 eng d | ||
| 022 | _a0077-8923 | ||
| 024 | 7 |
_a10.1196/annals.1405.030 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTitulaer, Maarten J | |
| 245 | 0 | 0 |
_aLambert-Eaton myasthenic syndrome: tumor versus nontumor forms. _h[electronic resource] |
| 260 |
_bAnnals of the New York Academy of Sciences _c2008 |
||
| 300 |
_a129-34 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAge of Onset |
| 650 | 0 | 4 |
_aAntibodies, Antinuclear _ximmunology |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aHealth |
| 650 | 0 | 4 |
_aHistocompatibility Antigens _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLambert-Eaton Myasthenic Syndrome _ximmunology |
| 700 | 1 | _aVerschuuren, Jan J G M | |
| 773 | 0 |
_tAnnals of the New York Academy of Sciences _gvol. 1132 _gp. 129-34 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1196/annals.1405.030 _zAvailable from publisher's website |
| 999 |
_c18052227 _d18052227 |
||